Mr Jin Yang
Tenaya Therapeutics, South San Francisco (United States of America)
Member of:
/f/125658/3386x1417/951de003e4/hfa-acronym-name-rgb.png)
HDAC6 inhibition reduces cardiac fibrosis, enhances mitochondrial function and demonstrates comparable efficacy as empagliflozin in a mouse model of heart failure with preserved ejection fraction
Event: Heart Failure 2022
Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)
Session: Heart Failure ePosters - focus on Chronic Heart Failure 5
HDAC6 inhibition improves diastolic function in a mouse model of heart failure with preserved ejection fraction
Event: Heart Failure 2021
Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)
Session: Chronic Heart Failure - Pathophysiology and Mechanisms 1
ESC 365 is supported by
